Amgen to Acquire Five Prime Therapeutics for $1.9 Billion in Cash
4 Mar 2021
Amgen (NASDAQ: AMGN) and Five Prime Therapeutics (NASDAQ: FPRX), a clinical-stage biotechnology company focused on developing immuno-oncology and targeted cancer therapies.
Servier to Acquire Oncology Business from Agios Pharmaceuticals
21 Dec 2020
In-line with Servier's strategy, this acquisition will enable the Group to strengthen its product portfolio and drug development pipeline in oncology.
Merck KGaA, Darmstadt, Germany and Artios Pharma Announce a Global Strategic Collaboration on Novel DNA Damage Response Targets in Oncology
3 Dec 2020
The acquisition will establish a new modality for drug discovery and development at Lilly, extending Lilly's research efforts through the creation of a gene therapy program that will be anchored by Prevail's portfolio of clinical-stage and preclinical neuroscience assets.
Merck to Acquire VelosBio for $2.75bn
5 Nov 2020
KENILWORTH, N.J. & SAN DIEGO--(BUSINESS WIRE) - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and VelosBio Inc.
Sanofi Offers to Acquire Kiadis, a Clinical-stage Company Developing Cell-based Immunotherapy Products
2 Nov 2020
PARIS and AMSTERDAM – Sanofi and Kiadis, a clinical-stage biopharmaceutical company developing innovative 'off the shelf' natural killer (NK) cell based medicines for the treatment of life-threatening diseases
Join Our Newsletter for Free
